New Drugs Are Replacing Chemo for Aggressive Breast Cancer
The FDA has granted broad first-line approval for Gilead's Trodelvy, signaling a shift away from traditional chemotherapy for aggressive breast cancer.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Gilead's drug Trodelvy has received FDA approval for use in first-line triple-negative breast cancer (TNBC). The treatment may be administered alone or in combination with Keytruda.
Coverage from Endpoints News, Fierce Pharma, and Cure Today emphasizes that this move positions Trodelvy as a front-line therapy. The Wall Street Journal reports that new drugs are replacing chemotherapy for aggressive breast cancer, while FirstWord Pharma notes the drug has secured a pair of approvals in the US.
Industry focus now turns to the TROP2 ADC market, which Fierce Pharma describes as a site of ongoing competition.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 4h ago.
Quick answers
What is Trodelvy approved for?
It is FDA-approved for first-line triple-negative breast cancer (TNBC).
Can Trodelvy be used with other medications?
Yes, it is approved for use alone or in combination with Keytruda.
Who manufactures Trodelvy?
The drug is produced by Gilead.
Coverage (6)
- Sacituzumab Govitecan Gains First-Line TNBC Indications Medscape · 1d ago
- Gilead's Trodelvy claims a pair of breast cancer approvals in the US FirstWord Pharma · 1d ago
- FDA backs Gilead’s Trodelvy for first-line, triple-negative breast cancer Endpoints News · 1d ago
- FDA Approves Trodelvy Alone or With Keytruda for First-Line Triple-Negative Breast Cancer Cure Today · 1d ago
- Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war Fierce Pharma · 1d ago
- New Drugs Are Replacing Chemo for Aggressive Breast Cancer WSJ · 1d ago broke it first
People, places & organizations
Topics
Related trends
The Wearable Data Your Doctor Actually Wants
Wearable technology is shifting from general fitness tracking toward clinical healthcare integration and Medicare eligibility.
US provides Ebola treatment for outbreak in Congo, bringing trials closer
US provides experimental Ebola treatment for Congo outbreak
HHS Launches Unprecedented Department-Wide Effort to Restore American Leadership in Clinical Trials
The U.S. Department of Health and Human Services is launching a department-wide effort to accelerate clinical trials and restore American leadership in medical research.